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ABSTRACT 
Smoker, Michael P. M.S., Purdue University, May 2016. Effect of Central Amygdala 
Gabra2 Expression on Anxiety and Alcohol’s Anxiolytic Capacity in C57BL/6J Mice. 
Major Professor: Stephen L. Boehm, II. 
The GABRA2 gene, which encodes the α2 subunit of GABAA receptors, is one of 
the genes most frequently associated with alcohol-related behavior in human studies 
(Demers, Bogdan, & Agrawal, 2014).  Polymorphisms in GABRA2 have been found to be 
associated with alcohol dependence, changes in drinking frequency, and alcohol’s 
stimulating and euphoric effects (Arias et al., 2014; Dick et al., 2014; Edenberg et al., 
2004).  However, the GABRA2-alcohol relationship may not be direct, as anxiety and 
impulsiveness have been found to be mediating factors (Enoch, Schwartz, Albaugh, 
Virkkunen, & Goldman, 2006; Villafuerte, Strumba, Stoltenberg, Zucker, & Burmeister, 
2013). 
 Comorbidity of anxiety and alcohol use disorders is both prevalent and clinically 
relevant (J. P. Smith & Randall, 2012), and GABAA receptors play a significant role in 
each.  Benzodiazepines, primary pharmacologic treatments for anxiety disorders and 
alcohol withdrawal, facilitate signaling at GABAA receptors, and their anxiolytic effects 
appear to depend on the presence of α2 subunits in these receptors (Low et al., 2000).  
The amygdala is widely implicated in both anxiety disorders as well as addiction (Janak 
& Tye, 2015), and its central nucleus is an important mediator of responses to both 
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alcohol- and stress-related stimuli (Roberto, Gilpin, & Siggins, 2012), some of which 
may be related to GABRA2 expression within this region (Jin et al., 2014).  
The aim of the current study was to explore the role of Gabra2 (mouse ortholog 
of GABRA2) expression within the central nucleus of the amygdala (CeA) in anxiety-
related behavior and alcohol’s anxiolytic effects in mice.  C57BL/6J (B6) mice 
underwent surgery for bilateral infusion of GFP-tagged lentivirus targeting Gabra2 or a 
scramble control lentivirus into the CeA.  Following 12-13 days of recovery, mice were 
assessed for anxiety-like behavior in the elevated plus maze (EPM) naïve or following IP 
injection of 0, 0.75, or 1.5 g/kg ethanol.  After assessment, brains were extracted and 
sectioned through the CeA.  Finally, GFP was quantified, the CeA was collected via laser 
microdissection, and α2 protein was quantified via ELISA. 
In mice expressing GFP in the CeA, α2 protein concentrations were lower for 
Virus mice relative to Control mice.  The EPM was anxiogenic, and alcohol was found to 
be anxiolytic.  In naïve mice, while there was no difference between Control mice and 
Virus mice on any behavioral measure, there were significant correlations between CeA 
α2 protein concentration and time spent in closed arms as well as both total and average 
time spent in open arms.  In mice receiving injection of 0, 0.75, or 1.5 g/kg ethanol, there 
was a main effect of dose on several behavioral measures, but no interaction between 
viral condition and dose, and only a main effect of viral condition on average time spent 
in closed arms.  There were no significant correlations between CeA α2 protein 
concentration and behavioral measures within any injected dose.  These results are 
consistent with GABRA2-anxiety associations and effects of Gabra2 manipulation on 
anxiety-like behavior.  Furthermore, they suggest that CeA α2 protein concentration is 
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positively related to basal anxiety, which could affect alcohol use through various routes.  
However, these results also suggest that CeA α2 protein concentration is not related to 
alcohol’s anxiolytic capacity, at least when acutely administered in alcohol-naïve 
animals.   
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CHAPTER 1 INTRODUCTION 
 
 
 
1.1 GABRA2 & Alcohol-Related Behavior 
Alcohol is a widely consumed drug, and its abuse can lead to negative individual 
and social consequences.  Many of alcohol’s neurobehavioral effects result from its 
interaction with GABA signaling within the central nervous system, and in particular 
with GABAA receptors.  These receptors are ligand-gated and composed of five protein 
subunits, and their functional properties can vary depending on subunit combinations.  
Among these possible protein subunits is α2, which is encoded by the GABRA2 gene, one 
of the genes most frequently associated with alcohol-related behavior in human studies 
(Demers et al., 2014).   
 Some of the earliest evidence for a GABRA2-alcohol association was with respect 
to alcohol dependent individuals.  In a sample of individuals with a family history of 
alcohol dependence, Edenberg et al. (2004) found 31 single nucleotide polymorphisms 
(SNPs) within the GABRA2 gene to be associated with dependence.  Furthermore, Soyka 
et al. (2008) found an association between a single, 8-SNP haplotype in GABRA2 and 
dependence between treatment-seeking dependent and non-dependent individuals.  These 
results support a relationship between GABRA2 polymorphisms and chronic alcohol 
consumption.  
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GABRA2 has also been associated with alcohol-related behavior outside of 
dependence.  In a longitudinal study examining drinking frequency, allelic variation at 6 
SNPs within GABRA2 was associated with a greater increase in drinking frequency 
during the transition from adolescence to adulthood (Dick et al., 2014).  Additionally, 
several studies have found associations between single or multiple GABRA2 SNPs and 
the subjective effects of acutely administered alcohol.  These include increased 
stimulation and euphoria (Arias et al., 2014), increased happiness and vigor (Haughey et 
al., 2008), and decreased negative effects (Uhart et al., 2013) following oral 
administration, as well as increased stimulation and liking following IV administration 
(Haughey et al., 2008).  Taken as a whole, the evidence points to a significant 
relationship between GABRA2 and alcohol-related behavior, including both chronic use 
and acute subjective effects. 
As manipulation of GABRA2 in humans is not currently feasible, non-human 
animals can be extremely useful, and studies with rodents also support the relationship 
between GABRA2 and alcohol.  Alterations in α2 expression have been found following 
selection for alcohol consumption and preference, with greater α2 mRNA expression in 
the nucleus accumbens (NAc) of HAP vs LAP mice (Boehm, unpublished) and greater 
α2 protein expression in the CeA of P vs NP rats (Liu et al., 2011).  That these rodents 
were alcohol-naïve suggests that α2 alterations might play a role in alcohol consumption 
or preference.   
Experimental manipulation of α2 expression also supports its role in alcohol-
related behavior.  Boehm II et al. (2004) found that α2 knock-out mice had a reduction in 
the duration of alcohol-induced loss-of-righting reflex (LORR), a measure of alcohol’s 
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hypnotic effects.  Furthermore, α2 knock-out mice showed a reduction in alcohol 
consumption and preference, but this was only the case in females.  However, their (non-
significant) reduced preference for bitter taste (quinine) may also have contributed to this 
effect.  Although not part of this study, α2 knock-out mice have also been found to show 
a reduction in conditioned taste aversion (CTA) to alcohol (Blednov, unpublished).  In a 
more refined approach to assessing the role of α2 subunits in alcohol-induced behavioral 
responses, Blednov et al. (2011) used knock-in mice containing point mutations at 
specific amino acids which yielded functional, but alcohol-insensitive α2-containing 
GABAA receptors.  These knock-in mice showed both decreases and increases in alcohol 
consumption and preference depending on the paradigm (2-bottle choice, 1-bottle DID, 
or 2-bottle DID), access schedule (continuous or limited) and sex.  Overall, there was no 
alcohol-drinking assessment that yielded a lack of effect in knock-in mice.  In addition, 
these mice showed an increase in the duration of alcohol-induced LORR and a decrease 
in alcohol-induced CTA and locomotion.  While the results of these studies suggest a role 
of α2-containing receptors in multiple alcohol-related behaviors, the implications are not 
completely clear as there were differences in effects based on study, paradigm, and sex.  
Furthermore, an effect of compensatory structural or functional changes within these 
congenital knock-out/in mice cannot be ruled out. 
1.2 Anxiety’s Mediation of GABRA2 & Alcohol-Related Behavior 
Both human and rodent data suggest, relatively consistently, a relationship 
between GABRA2 and alcohol-related behavior.  However, this relationship may not 
always be direct, as human studies indicate that there may be important mediating 
factors, including anxiety and impulsiveness (Enoch et al., 2006; Villafuerte et al., 2013), 
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with anxiety being of particular interest for this study.  Enoch et al. (2006) used two 
distinct populations, Finnish and Plains American Indian, to investigate a potential 
GABRA2-alcohol-anxiety relationship.  GABRA2 SNPs were associated with alcoholism 
in both populations, replicating previous findings.  Furthermore, risk (of alcohol 
dependence)-conferring haplotype configurations within GABRA2 were associated with 
harm avoidance (a measure of trait anxiety) but not associated with alcoholism.  Harm 
avoidance was higher in alcoholics, and haplotype frequencies varied with level of harm 
avoidance, but only for alcoholics.  These results indicate that some of the relationship 
between GABRA2 haplotype and alcoholism can be revealed when anxiety is taken into 
consideration.  Additionally, it has been suggested that anxiety may partly explain the 
discrepancy between the ability of high- and low-risk GABRA2 alleles to differentiate the 
effects of various psychosocial treatments in alcoholics (Bauer et al., 2007). 
1.3 GABRA2 & Anxiety-Related Behavior 
Given the prevalence and clinical relevance of comorbidity of anxiety and alcohol 
use disorders (J. P. Smith & Randall, 2012), as well as the significant role that GABAA 
receptors play in these disorders, it would not be surprising if GABRA2 played a role in 
both, and possibly even their overlap.  Studies in rodents with global α2 expression 
manipulation tend to support its role in anxiety, but results aren’t unequivocal.  α2 knock-
out mice have been found to display more risk assessment and longer latencies to explore 
a novel environment during free-choice exploration, as well as less time in light and more 
time in the tunnel during a light/dark (L/D) choice situation (Koester et al., 2013).  In 
addition, mice with alcohol-insensitive α2-containing receptors have displayed a reduced 
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percentage of open arm entries in the elevated plus maze (EPM) (Blednov et al., 2011).  
These results indicate a role for α2 expression in basal anxiety.   
With respect to drug-induced anxiolysis, the results are mixed.  Boehm II et al. 
(2004) found no significant difference in alcohol’s anxiolytic effects in the EPM in α2 
knock-out mice, and the same was true of mice with alcohol-insensitive, α2-containing 
receptors (Blednov et al., 2011).  However, when looking at studies with mutant mice 
containing point mutations rendering GABAA receptors containing specific subunits (α1, 
α2, or α3) insensitive to modulation by benzodiazepines, the evidence for an α2-
anxiolysis relationship is strong.  Low et al. (2000) found that only α2 mutant mice 
showed no effect of diazepam on time in light in the L/D test and open arm time and 
entries in the EPM.  Furthermore, only α2 mutant mice have shown a consistent lack of 
effect of diazepam and chlordiazepoxide in EPM and fear-potentiated startle assessments 
without affecting locomotor activity (K. S. Smith, Engin, Meloni, & Rudolph, 2012).  
Benzodiazepines are effective anxiolytics in non-mutated mice, and while multiple 
GABAA α-subunits are implicated in a number of benzodiazepines’ behavioral effects, it 
appears that α2-containing GABAA receptors play a principal role in mediating their 
anxiolytic effects.  That global α2 expression manipulations in rodents tend to alter the 
anxiolytic properties of benzodiazepines but not alcohol might suggest a drug-specific 
relationship between α2 expression and anxiolysis.  However, evidence from region-
specific studies (discussed below) suggests that targeted investigation of the role of α2 
expression in alcohol’s anxiolytic effects is warranted. 
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1.4 GABAA Involvement in CeA-Mediated Behavior 
The amygdala is widely implicated in both anxiety disorders and addiction, and 
its circuitry is well conserved across species, allowing for meaningful translational 
research (Janak & Tye, 2015).  Based on location and connectivity, the CeA is an 
important mediator of responses (physiological and behavioral) to alcohol- and stress-
related stimuli (Roberto et al., 2012), leading to the possibility of behaviorally-relevant, 
alcohol-anxiety interactions in this region.  With respect to alcohol, acute administration 
in rats or mice increases c-Fos expression in the CeA (McBride, 2002), and CeA lesions 
have been shown to reduce alcohol intake in a 2-bottle choice procedure (Moller, 
Wiklund, Sommer, Thorsell, & Heilig, 1997).  In rats, infusion of a GABAA antagonist 
(SR5531) into the CeA has been shown to decrease responding for alcohol in an operant 
choice task at lower concentrations than infusion into other brain regions (Hyytia & 
Koob, 1995); infusion of a selective, α1 GABAA benzodiazepine mixed 
agonist/antagonist (βCCt) into the CeA has been shown to decrease responding for 
alcohol, with and without sucrose (Foster et al., 2004); and infusion of a GABAA agonist 
(muscimol) into the CeA has been shown to substitute for alcohol in a discrimination task 
(Hodge & Cox, 1998).  With respect to anxiety, lesions of the CeA in rats have been 
shown to abolish the anxiogenic effects of restraint stress in the EPM (Moller et al., 
1997).  Furthermore, rats infused with muscimol or midazolam in the CeA have shown a 
reduction in a number of anxiety-related behaviors in the EPM, and these effects were not 
present after infusions in the basolateral amygdala (Carvalho, Moreira, Zanoveli, & 
Brandao, 2012; Moreira, Masson, Carvalho, & Brandao, 2007).  These results indicate a 
role for the CeA broadly, and GABAA receptors within the CeA specifically, in 
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subjective and behavioral responses to alcohol as well as in the exhibition of anxiety-
related behaviors.   
Alcohol- and anxiety-related responses/behaviors also appear to interact within 
the CeA based on the following studies assessing CeA-mediated anxiety-related 
behaviors in the context of prior alcohol exposure.  Sharko, Kaigler, Fadel, and Wilson 
(2013) split rats into high- and low-drinking groups after multiple, limited-access alcohol 
sessions and found an increase in the percent time in open arms in the EPM in the high-
drinking group as well as higher c-Fos activation in the CeA, which was correlated with 
both alcohol intake and percent time in open arms.  Rassnick, Heinrichs, Britton, and 
Koob (1993) infused a corticotropin-releasing factor (CRF) antagonist into the CeA (and 
intracerebroventricularly) and assessed anxiety in the EPM after withdrawal from either 
an alcohol- or sucrose-based liquid diet.  CRF antagonism was found to be anxiolytic, but 
only after infusion into the CeA, and only in alcohol-dependent rats.  The fact that the 
aforementioned effects were only found in animals with prior (high) alcohol experience 
suggests the possibility that alcohol-related alterations in the CeA are relevant to 
expression of anxiety-related behavior. 
1.5 GABRA2 & the CeA 
 GABRA2 is expressed at relevant levels in the CeA of multiple species.  
There is moderate to strong expression of α2 protein in the rat CeA (Pirker, Schwarzer, 
Wieselthaler, Sieghart, & Sperk, 2000) and α2 mRNA and protein expression in the 
mouse CeA (Hortnagl et al., 2013), and concerning GABAA subunit distribution in the 
(extended) amygdala, α2 protein expression is most prominent in the CeA (and NAc, 
BNST) while α1 protein expression is most prominent in the lateral amygdala (and VP).  
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With respect to alcohol, post-mortem analysis of CeA tissue from humans has revealed 
decreases in mRNA expression of a number of glutamate receptor subunits, but only one 
GABA receptor subunit, α2, in alcoholics compared to controls (Jin et al., 2014).  
Additionally, both alcohol-naïve and alcohol-exposed P rats have been shown to have 
increased expression of α2 (and α1) protein compared to NP rats in the CeA (Liu et al., 
2011).  Although these human and rat results differ in direction and expression measure, 
they both indicate a relationship between α2 expression in the CeA and a chronic alcohol 
consumption phenotype.  With respect to anxiety, diazepam-modulated inhibitory post-
synaptic currents have been shown to be mediated by α2-containing receptors in the CeA 
and α1- and α2-containing receptors in the lateral/basolateral amygdala in mutant mice 
with diazepam-insensitive α1-, α2-, or α3-containing GABAA receptors (Marowsky, 
Fritschy, & Vogt, 2004).  This goes beyond the effects of the lesioning of, and GABAA 
agonism within, the CeA on anxiety to provide evidence for the importance of α2 
subunits in the CeA in regulating benzodiazepine-induced inhibition and related 
anxiolysis. 
In what appears to be the only study with direct manipulation of α2 expression 
specifically in the CeA including an assessment of behavior, Liu et al. (2011) infused P 
rats with virally-mediated, small interfering RNA (siRNA) targeting either α1 or α2 
subunit expression in the CeA, NAc, or ventral pallidum (VP) and assessed them on an 
operant, multiple-scheduled-access procedure.  siRNA infusions resulted in a drastic 
reduction from baseline responding for alcohol (but not sucrose) when targeting α2 in the 
CeA and when targeting α1 in the VP, providing strong evidence for subunit-specific, 
subregion-specific effects within the extended amygdala.  Interestingly, alcohol and 
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sucrose responding were both lower on the first day of assessment post-surgery; however, 
while sucrose responding returned immediately thereafter, alcohol responding slowly 
returned to baseline over the course of several days, which could suggest a stress-alcohol- 
α2 interaction within the CeA. 
In summary, GABRA2 appears to play a role in both alcohol- and anxiety-related 
behavior.  The CeA is an important substrate for the mediation of these behaviors, and 
α2-containing GABAA receptors within this region appear to play an important role in 
each.  The prospect that this subunit’s expression within the CeA might play a role in 
their interaction (alcohol-induced anxiolysis) is intriguing.  However, there appear to 
have been no studies manipulating α2 expression exclusively in the CeA and assessing its 
effects on basal anxiety and alcohol-induced anxiolysis.  The current study sought to fill 
this gap. 
1.6 Specific Aims 
1. Determine the appropriate parameters and dosage for assessing anxiety and 
alcohol’s anxiolytic effects in the elevated plus maze in C57BL/6J mice.   
2. Assess the effects of virally-mediated, Gabra2 knock-down in the central nucleus of 
the amygdala on basal anxiety and alcohol’s anxiolytic effects in the elevated plus 
maze in C57BL/6J mice.   
 
10 
 
 
 
CHAPTER 2 EFFECT OF CENTRAL AMYGDALA GABRA2 EXPRESSION ON 
ANXIETY AND ALCOHOL’S ANXIOLYTIC CAPACITY 
2.1 Materials and Methods 
2.1.1 General Design 
In brief, male B6 mice in Aim 1 were assessed in the EPM naïve or following IP 
injection of 0, 0.75, 1.0, or 1.5 g/kg ethanol to determine the appropriate parameters for 
subsequent assessment with viral manipulation.  Male B6 mice in Aim 2 underwent 
surgery for bilateral infusion of GFP-tagged lentivirus targeting Gabra2 or a scramble 
control lentivirus into the CeA.  Following 12-13 days of recovery, mice were assessed in 
the EPM naïve or following IP injection of 0, 0.75, or 1.5 g/kg ethanol.  After assessment, 
brains were extracted and sectioned through the CeA.  Finally, GFP was quantified, the 
CeA was collected via laser microdissection, and α2 protein was quantified via ELISA. 
2.1.2 Subjects 
For Aim 1, a total of 60 male B6 mice were obtained from Jackson Labs (Bar 
Harbor, ME) at 8 weeks of age.  For Aim 2, a total of 104 male B6 mice were obtained 
from Jackson Labs at 8 weeks of age, and of these, 6 mice died during or after surgery 
and 2 mice were not used due to cagemate death, leaving a total of 96 mice used for 
experimentation.  Mice were 9-10 weeks of age at the time of surgery and 11-12 weeks of 
age at the time of behavioral assessment.  All mice had ad libitum access to food and 
water for the duration of the experiment and were pair-housed (except for 5-6 days during 
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recovery from surgery) under a 12-hour, reverse light/dark schedule, with lights off at 
8:00 am.  Procedures were approved by the IUPUI School of Science Institutional 
Animal Care and Use Committee and conformed to the Guide for the Care and Use of 
Laboratory Animals (The National Academic Press, 2003). 
2.1.3. Surgery 
Mice were anesthetized with a 0.01 ml/g IP injection of a ketamine/xylazine 
cocktail (10:1:89 ratio of ketamine (100 mg/ml), xylazine (100 mg/ml), and 0.9% sterile 
saline, respectively).  Once anesthetized, mice had their heads shaved and were placed in 
a Kopf stereotaxic alignment system (Tujunga, CA).  Mice’s eyes were kept moist with 
commercially available tear ointment.  A small incision was made from approximately 
bregma to lambda, and the skull was sterilized with 70% alcohol and Nolvasan 
disinfectant.  For accuracy, the distance between bregma and lambda was measured and 
divided by 4.21 mm, the published average distance between lambda and bregma for B6 
mice (Franklin and Paxinos, 1997), to create a scaling factor for each mouse.  The 
targeted coordinates for the CeA (-1.20 mm A/P, ±2.80 mm M/L, and -4.85 mm D/V) 
were adjusted by the scaling factor, and one hole was drilled in the skull in each 
hemisphere above the CeA.  A microinjection syringe (Hamilton Co., Reno, NV) was 
twice lowered into the CeA to bilaterally infuse a GFP-tagged lentivirus targeting Gabra2 
(Virus) via short hairpin RNA (shRNA) or a GFP-tagged scramble control lentivirus 
(Control) (Sigma-Aldrich, Inc., St. Louis, MO).  An illustration and description of RNA 
interference via shRNA are given in Figure 1.  Viruses were diluted 1:1 with 0.9% sterile 
saline, as exploratory surgery indicated this reduces extra-regional incorporation.  This 
produced final titers of 2.4 x 109 and 2.2 x 109 TU/ml for Virus and Control lentiviruses, 
12 
 
 
 
respectively.  0.15 µl of virus was infused at a rate of 0.1 µl/min and allowed to diffuse 
for an additional 10 minutes.  The microinjector was raised 0.05 mm between infusion 
and diffusion, as exploratory surgery indicated this reduces residual virus on the 
microinjector tip.  Between infusions, the syringe pump (World Precision Instruments, 
Sarasota, FL) was run until virus was visible in order to confirm patency.  Following 
infusions, incisions were sealed with VetBond skin glue (3M Animal Care, St. Paul, 
MN), and mice received 0.01 ml/g SC injections of buprenorphine (0.03 mg/ml) and 
rimadyl (5 mg/ml) for analgesia and anti-inflammation, respectively.  Following surgery, 
mice were single-housed in a biohazard-approved, filter-top cage for 5-6 days of recovery 
and subsequently pair-housed with their original cagemate, with 4 exceptions.  2 mice 
were housed with an age-matched, surgery-naïve mouse, and 2 mice were housed with 
each other due to the death of their original cagemate during surgery. 
2.1.4. EPM Assessment 
The testing room was separated by a canvas curtain into two sections, one under 
red light (the same conditions as the vivarium) and the other, containing the EPM, under 
red light plus dim ambient lighting.  The EPM (Med Associates, Inc., St. Albans, VT) 
was black in color, was 74.5 cm above the ground, and had arms measuring 76.0 cm in 
length.  The closed arms had walls measuring 20.5 cm, and the open arms had no walls, 
but a slight lip on the sides but not ends.  The luminance across testing was 26±2, 5±1, 
and 33±2 lux for Aim1 and 43±1, 6±1, and 54±4 lux for Aim 2, for the center, closed 
arms, and open arms, respectively.  Luminance was increased slightly in Aim 2 in order 
to enhance the EPM’s anxiogenic nature. 
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Previous work in our lab has shown viral incorporation and significant effects on 
alcohol consumption at 2 weeks post-infusion (Boehm, unpublished).  Therefore, mice 
were assessed in the EPM following 12-13 days of recovery from surgery.  Mice were 
transported to the testing room 5 minutes prior to lights off (8:00 am) and allowed to 
habituate in the non-maze portion of the testing room for at least 1 hour prior to 
assessment.  Prior to placement on the EPM, each mouse was weighed and placed in an 
empty holding cage for 10 minutes.  During this time, injected mice were taken just 
outside the testing room for 30 seconds to receive an IP injection of either 0, 0.75, or 1.5 
g/kg of 20% ethanol in 0.9% sterile saline (Aim 1 also included a 1.0 g/kg dose).  All 
injections took place 10 minutes prior to placement in the EPM.  Mice were placed in the 
center of the EPM, facing an open arm, and allowed to explore for 5 minutes while being 
video-recorded by a camera mounted directly overhead.  All condition-dose combinations 
were represented on each testing day except for 2 instances.   
Following assessment, the number of fecal boli were counted, and the EPM was 
cleaned with Clidox-S.  Retro-orbital sinus blood samples were collected in Aim 1 from a 
subset of mice in each injection condition (n’s = 8) to determine BEC resulting from IP 
administration of ethanol.  Videos were later scored for entries and time spent in center, 
closed arms, and open arms as well as the number of head dips made.  Mice were 
considered to have entered an arm when all 4 paws transitioned from outside to inside an 
arm and considered to be in an arm as long as all 4 paws remained inside.  Mice were 
considered to have made a head dip when the shoulders moved forward and the head was 
facing downward over the edge of the EPM.  Head dips were differentiated as protected 
when initiated from outside of an open arm. 
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2.1.5. Histology 
Approximately 2-4 hours after assessment in the EPM, mice’s brain were 
extracted, flash frozen in 2-methylbutane at < -40o C, and stored at -80o C until 
processed.  Brains were sliced in a cryostat at -16o C.  Serial sections through the CeA at 
35 µm thickness were mounted to PEN-Membrane slides, dehydrated with ascending 
concentrations of ethanol (70% - 5 sec, 95% - 5 sec, 100% - 20 sec), and stored at -80o C 
until microdissection.  For sections containing the CeA, tissue was laser microdissected 
using the following technique.  The area expressing GFP was encircled under 5x 
magnification with fluorescence using laser microdissection software (Leica Biosystems 
Inc., Buffalo Grove, IL), which calculates area in nm2.  Bilateral CeA was then laser 
microdissected under 5x magnification in bright field while referencing a mouse brain 
atlas (Paxinos & Franklin, 1997), and the tissue was captured in 1x RIPA buffer (1x 
RIPA buffer with 100 µl/ml of 10x PI and 10 µl/ml of 20x PMSF).  The remaining area 
expressing GFP was again encircled and calculated under 5x magnification with 
fluorescence.  Bilateral CeA tissue was collected from all sections whether or not they 
expressed GFP fluorescence.  The pre- and post-microdissection GFP area calculations 
were used to estimate the amount of GFP expressing tissue within and without the CeA.  
Tissue samples were homogenized manually, and total protein concentration was 
calculated for each.  Samples were assessed via ELISA (MyBioSource, Inc., San Diego, 
CA), in triplicate and with 60 µg of total protein loaded per sample, for quantification of 
α2 protein concentration according to the manufacturer’s suggested procedures.  An 
illustration and description of the sandwich ELISA assay are given in Figure 2.  A total 
of 4 ELISA assays were needed to assess all samples, with all 3 samples from each brain 
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run within one assay, and the mean value of samples from each brain was used as the α2 
protein concentration. 
2.1.6. Statistical Analysis 
Statistical significance for all analyses was set at p < .05.  For Aim 1, 
confirmation of the anxiogenic nature of the EPM was assessed using only naïve mice.  
Both a single-sample t-test comparing % of entries in open arms to 50% and a paired-
samples t-test comparing time spent in the open vs. closed arms were run.  To determine 
appropriate doses for future assessment in Aim 2, the following measures were submitted 
to a one-way ANOVA with dose (0, 0.75, 1.0, 1.5 g/kg) as the lone factor, using only 
mice receiving injection: % of entries in open arms, time spent in open arms, and total 
arm entries.  Each ANOVA was followed by Dunnett’s test using the 0 g/kg dose as the 
reference. 
For Aim 2 histological analyses, only mice expressing GFP in the CeA were 
included, and mice with total protein and/or α2 protein concentration values ≥ 3 SD from 
the overall mean were excluded (see Table 1 for n’s).  Consistency of ELISA output was 
assessed using a one-way ANOVA on α2 protein concentrations, with ELISA pass as the 
lone factor, for Control mice only.  Because there was a significant effect of ELISA pass 
on α2 protein concentrations, F(3,27) = 3.84, p = .021, mean α2 protein concentrations 
for all mice were normalized via z-score transformations based on distributions within 
their respective ELISA pass (Fig. 5A).  Normalized (z-score) values were used to 
represent α2 protein concentrations for all subsequent analyses.  A one-tailed, 
independent samples t-test was used to test the prediction that α2 protein concentrations 
would be lower in the Virus relative to the Control condition.  
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For Aim 2 behavioral analyses, only mice expressing GFP in the CeA were 
included, and mice with ≤ 1 open arm entry or an environmental confound (noise during 
assessment) were excluded (see Table 1 for n’s).  To limit the influence of general 
activity levels on measures of arm entries, the % of entries in open arms ((open/total) x 
100) was calculated for each mouse.  In addition, % of head dips protected 
((protected/total) x 100) was calculated for each mouse.  Lastly, latency to first arm entry 
and fecal boli were largely unrelated to other EPM measures and were not analyzed 
further (Table 2).  The following behavioral measures were used as dependent variables 
for analyses: total arm entries; % of entries in open arms; total and average time spent in 
the center, closed arms, and open arms; head dips; and % of head dips protected.  To 
assess the effect of viral condition on basal anxiety, these measures were each submitted 
to an independent-samples t-test comparing Control to Virus using only naïve mice.  To 
assess both alcohol’s anxiolytic capacity and potential augmentation by viral condition, 
these measures were each submitted to a two-way ANOVA with viral condition and dose 
as factors using only mice receiving 0, 0.75, or 1.5 g/kg ethanol injections.  Main effects 
of dose were followed by Dunnett’s test using the 0 g/kg dose as the reference, and main 
effects of viral condition were followed by Bonferroni-corrected t-tests comparing 
Control to Virus within each dose. 
 For Aim 2 brain-behavior correlations, all mice were included, with the following 
exceptions: mice with total protein and/or α2 protein concentration values ≥ 3 SD from 
the overall mean and mice with ≤ 1 open arm entry or an environmental confound (see 
Table 1 for n’s).  The relationships between α2 protein concentrations and behavioral 
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measures in the EPM, as well as the relationships between the various EPM behavioral 
measures, were assessed using Pearson correlations. 
2.2 Results 
2.2.1. Aim 1 
The anxiogenic nature of the EPM was confirmed for this experiment by mice 
making significantly fewer open arm entries than would be expected by chance (50%), 
t(11) = -4.15, p = .002 and by mice spending significantly less time in open vs. closed 
arms, t(11) = 6.35, p < .001 (data not shown).  The anxiolytic capacity of alcohol was 
confirmed by a significant increase in the % of entries in open arms, F(3, 38) = 4.57, p 
= .008, with Dunnett’s test indicating that all doses differed significantly from 0 g/kg (p’s 
< .048) (Fig. 3A); however, alcohol was not found to affect either time spent in open 
arms, F(3, 38) = 1.63, p = .199 or total arm entries, F(3, 38) = 2.54, p = .071 (Figs. 3B 
and 3C, respectively).  Based on these results, the 0.75 and 1.5 g/kg doses were chosen 
for use in Aim 2.  These doses produced mean BEC values of 74.58 and 151.62 mg%, 
respectively. 
2.2.2. Histology 
Representative images showing both successful and unsuccessful viral 
incorporation with reference to a mouse brain atlas (Paxinos & Franklin, 1997) are shown 
in Figure 4.  As shown in Figure 5B, a one-tailed, independent-samples t-test revealed a 
decrease in normalized α2 protein concentrations for Virus mice relative to Control mice, 
t(62) = 1.81, p = .038, thus confirming the effectiveness of the virus in reducing 
expression of the target protein.  An assessment of the potential impact of dose on these 
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normalized protein concentrations via two-way ANOVA yielded no significant effect of 
dose or dose x condition interaction (p’s > .470, data not shown). 
2.2.3. EPM Assessment 
 The anxiogenic nature of the EPM was confirmed for this experiment by mice 
making significantly fewer open arm entries than would be expected by chance (50%), 
t(10) = -4.97, p = .001 and by mice spending significantly less time in open vs. closed 
arms, t(10) = 4.61, p = .001 (Figs. 6B and 7B/C, respectively).  Regarding basal anxiety 
in naïve mice, there were no significant differences between Control mice and Virus mice 
on any behavioral measure (p’s > .376) (Figs. 6, 7, and 8).  Regarding alcohol’s 
anxiolytic capacity in mice receiving 0, 0.75, or 1.5 g/kg ethanol injections, two-way 
ANOVA’s yielded a significant main effect of viral condition for average time spent in 
closed arms, F(1, 44) = 5.23, p = .027, with average time reduced in Virus mice relative 
to Control mice (Fig. 7E).  Post hoc independent-samples t-tests yielded no significant 
differences between Virus mice and Control mice at any given dose (p’s > .104).  In 
contrast to viral condition, a significant main effect of dose was found for several 
behavioral measures including % of entries in open arms, F(2, 44) = 9.73, p < .001, time 
spent in center, F(2, 44) = 7.10, p = .002, time spent in open arms, F(2, 44) = 3.60, p 
= .036, head dips, F(2, 44) = 7.20, p = .002, and % of head dips protected, F(2, 44) = 
4.98, p = .011 (Figs. 6B, 7A, 7C, 8A, and 8B, respectively).  Follow-up Dunnett’s tests 
using the 0 g/kg dose as the reference revealed that both the 0.75 and 1.5 g/kg doses 
increased % of entries in open arms (p = .03 and p < .001, respectively).  However, it was 
only the 1.5 g/kg dose that decreased time spent in center (p = .001), increased time spent 
in open arms (p = .022), increased head dips (p = .002), and decreased % of head dips 
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protected (p = .011).  There were no significant interactions between viral condition and 
dose for any behavioral measure (p’s > .186) (Figs.6, 7, and 8). 
2.2.4. Brain-Behavior Correlations 
Pearson correlations were run within each dose (and naïve) to further explore the 
potential relationship between CeA α2 protein concentration and behavior.  For naïve 
mice, normalized α2 protein concentration was significantly positively correlated with 
time spent in closed arms, r(22) = .449, p = .036 and significantly negatively correlated 
with both time spent in open arms overall r(22) = -.519, p = .013 and on average r(22) = 
-.463, p = .03 (Figs. 9A, 9B, and 9C, respectively).  There were no significant 
correlations between these measures in mice receiving 0, 0.75, or 1.5 g/kg ethanol (p’s 
> .068) (Table 2). 
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CHAPTER 3 DISCUSSION 
3.1. EPM & Alcohol’s Anxiolytic Capacity 
The current EPM parameters were confirmed to be anxiogenic in completely 
naïve mice (Aim 1) as well as mice having undergone surgery (Aim 2).  As expected, 
alcohol was found to be an effective anxiolytic in both Aims; however, this effect was 
more pronounced in Aim 2.  In addition to differential histories, naive (Aim 1) vs. 
surgery (Aim 2), EPM luminance was increased for Aim 2, and each aim was run as a 
separate experiment, so a direct comparison of alcohol’s anxiolytic capacity between 
them may not be appropriate.  However, these parameters did provide an appropriate 
context for the assessment of the effect of CeA Gabra2 expression on basal anxiety and 
alcohol’s anxiolytic capacity. 
3.2. Virally-Mediated Gabra2 Knock-Down 
 Several mice in this experiment exhibited no GFP expression, yet all mice had 
visible needle track marks in or near the CeA.  Lack of expression could have been due to 
clogged/blocked microinjector tips or ineffective viral incorporation.  Although, 
considering the majority of mice exhibited GFP expression, ineffective incorporation 
seems much less likely.  Quantification of the area of GFP expression within the CeA 
was intended to provide an indirect measure of the amount/degree of viral incorporation.  
While there should have been no relationship between CeA GFP expression and α2 
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protein concentration in Control mice, a negative relationship was expected for Virus 
mice, as more incorporation should have produced a greater knock-down.  On the 
contrary, there was a positive correlation between CeA GFP expression and α2 protein 
concentration in Virus mice.  Both the inability to measure GFP expression in three 
dimensions and the inability to account for the intensity of fluorescence could have been 
responsible for this unexpected result.  Therefore, GFP expression was useful as an 
indicator of viral incorporation but not as a measure of amount/degree of incorporation.  
Overall, lentivirus targeting Gabra2 was effective in reducing α2 protein concentrations 
relative to a scramble control lentivirus.   
3.3. CeA Gabra2 Expression & Basal Anxiety 
 The current study found no significant difference on any behavioral measure 
between naïve Control and Virus mice.  However, when looking at naïve mice 
collectively, there was a significant relationship between CeA α2 protein concentration 
and multiple behavioral measures.  This discrepancy could be accounted for by the fact 
that the statistically significant reduction in α2 protein concentrations seen for Virus mice 
relative to Control mice may not have been behaviorally significant.  Taken together, the 
results from naïve mice support a role for CeA Gabra2 expression in basal anxiety, 
specifically a positive relationship between CeA α2 protein concentration and anxiety-
like behavior.  In addition to the significant correlations, the relationships between α2 
protein concentration and behavior were all consistently in this direction (except average 
time spent in closed arms), and although not statistically significant, the difference in 
means between Control mice and Virus mice for these behaviors were also consistently in 
the same direction (except head dips). 
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 The current demonstration of a Gabra2-anxiety relationship is in line with several 
previous studies.  In humans, haplotype configurations within GABRA2 have been found 
to be associated with harm avoidance, the tendency to be anxious and fearful (Enoch et 
al., 2006).  Of course these haplotypes don’t indicate a specific change in α2 protein 
concentration, and these individuals likely had varied environmental histories.  Similarly, 
compared to wild-type mice, α2 knock-out mice show alterations in anxiety-like 
behavior, specifically increased risk-assessment in and latency to explore a novel 
environment as well as decreased time in light in a L/D test (Koester et al., 2013).  That 
this negative relationship between Gabra2 expression and anxiety-like behavior is 
opposite in direction to the current results could be due to a number factors including the 
congenital and global nature of the Gabra2 manipulation, the type of assessment used, 
and the different strain of mouse used (129X1/SvJ).  Nevertheless, it supports a Gabra2-
anxiety relationship in animals with controlled environmental histories.  The current 
results also implicate α2 protein concentration specifically in the CeA in affecting 
anxiety-like behavior.  Additional support for this relationship comes from the 
observation that naïve P rats have elevated CeA α2 protein concentrations compared to 
NP rats (Liu et al., 2011) and also display greater anxiety-like behavior in the EPM (R. B. 
Stewart, Gatto, Lumeng, Li, & Murphy, 1993).  Although there are likely several 
structural/functional differences between P and NP rats, the difference in CeA α2 protein 
concentrations is significant (~100% increase) and the direction of its relationship to 
behavior is the same as in the current study.  Finally, while the current results can’t rule 
out other brain-related factors as contributing to the observed behavioral differences, the 
fact that B6 mice are inbred, resulting in relatively homogeneous brain structure/function, 
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and that viral manipulation of the CeA produced significant alterations in α2 protein 
concentrations specifically in this region strengthens the interpretation that CeA Gabra2 
expression is positively related to basal anxiety. 
3.4. CeA Gabra2 Expression & Alcohol’s Anxiolytic Capacity 
 Although alcohol was clearly found to be anxiolytic in this study, affecting a 
number of EPM measures in a predictable fashion, there was no interaction between viral 
condition and dose on any measure and only a main effect of viral condition across doses 
on one measure, average time spent in closed arms.  That this behavior alone, and not in 
conjunction with behaviors typically reported in EPM studies (e.g. time spent in open 
arms and % of entries in open arms), was affected by viral condition decreases 
confidence in the interpretation that a reduction in α2 protein concentration is anxiogenic 
across these doses.  In fact, mean group differences for this behavior are most 
pronounced at the 0.75 and 1.5 g/kg doses, yet correlations indicate a null relationship 
and a weak relationship in the opposite direction for these doses, respectively.  
Furthermore, increases in average time spent in closed arms could be explained by 
behaviors not necessarily related to anxiety, like increases in grooming.  Finally, there 
were no significant relationships between α2 protein concentration and behavioral 
measures within any dose.  Taken together, these results suggest that alterations in CeA 
Gabra2 expression do not affect alcohol’s anxiolytic capacity. 
 A lack of effect of Gabra2 expression on alcohol’s anxiolytic capacity is 
consistent with a lack of effect seen in both α2 knock-out mice (Boehm II et al., 2004) 
and knock-in mice containing alcohol-insensitive α2-containing GABAA receptors 
(Blednov et al., 2011).  However, this is in contrast to the role of Gabra2 expression in 
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mediating the anxiolytic actions of benzodiazepines, as mice with benzodiazepine-
insensitive α2-containing GABAA receptors fail to show an anxiolytic response to these 
drugs in a number of behavioral assessments (Low et al., 2000; K. S. Smith et al., 2012).  
In addition, while modulation of inhibitory post-synaptic currents by diazepam in the 
CeA appears to be mediated by α2-containing GABAA receptors (Marowsky et al., 2004), 
the results of the current study do not suggest a role for CeA α2 subunits in alcohol’s 
pharmacologic actions.  This difference could be related to, among other things, alcohol’s 
enhancement of inhibitory GABAergic transmission in the CeA via both pre- and post-
synaptic mechanisms (Roberto, Madamba, Moore, Tallent, & Siggins, 2003) or alcohol’s 
interactions with anxiogenic CRF and anxiolytic neuropeptide Y (NPY) signaling in the 
CeA (Gilpin, Herman, & Roberto, 2015).  Taken together, these studies suggest a drug- 
or drug class- specific relationship between α2 subunits and anxiolysis. 
3.5. Conclusions, Limitations, & Future Directions 
The current study supports the idea that CeA α2 protein expression is positively 
related to anxiety.  Enoch et al. (2006) found that risk (of alcohol dependence)-conferring 
GABRA2 haplotypes were associated with trait anxiety, which was increased in 
alcoholics, and one could speculate that these individuals had increased CeA GABRA2 
expression.  However, post-mortem analysis of CeA tissue from alcoholics has revealed 
decreased GABRA2 mRNA expression (Jin et al., 2014).  These findings can be 
reconciled when considering that a substantial change in CeA α2 protein expression and 
corresponding change in basal anxiety in either direction could lead to increases in 
alcohol use via different routes.  Increased anxiety, associated with an increase in CeA α2 
protein expression, would lead to an increase in the opportunity for alcohol to provide 
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relief and acquire negatively-reinforcing properties.  This negative-reinforcement route is 
direct and fairly intuitive, and it is consistent with several models of human alcoholism 
(J. P. Smith & Randall, 2012).  On the other hand, decreased anxiety, associated with a 
decrease in CeA α2 protein expression, might lead to alcohol use through a more indirect 
route via a relationship with externalizing behaviors, which are commonly found to be 
comorbid with substance use disorders (SUDs) (Hofmann, Richey, Kashdan, & 
McKnight, 2009).  In a direct assessment of the relationship between anxiety, 
externalizing problems, and SUDs, Hofmann, Richey, Kashdan, and McKnight (2009) 
found that while having either an anxiety disorder or externalizing problems increased the 
probability of having a SUD, the probability of having a SUD for individuals with 
externalizing problems was decreased for those with a comorbid anxiety disorder 
compared to those without.  Thus anxiety can moderate the relationship between 
externalizing problems and substance use, with decreased anxiety being associated with 
greater substance use in those with externalizing problems.   
Interestingly, both GABRA2 and the amygdala have been associated with 
externalizing behaviors.  With respect to GABRA2, a risk (of alcohol dependence)-
conferring GABRA2 genotype has been found to be associated with a greater likelihood 
of maintaining elevated expression of externalizing behaviors across the transition from 
adolescence to adulthood (Dick et al., 2009).  With respect to the amygdala, preschool 
externalizing behavior has been shown to predict decreased amygdala volume in 
adolescence in males (Caldwell et al., 2015), and adolescents with conduct disorder have 
also been shown to have decreased amygdala volume (Wallace et al., 2014).  While there 
is growing evidence that GABRA2, anxiety, externalizing behavior, and alcohol use all 
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share some degree of interrelation, the exact nature of these relationships is not clear.  
Future studies could further investigate the GABRA2-anxiety relationship by assessing 
(central) amygdala structure/connectivity or activity in response to anxiogenic 
cues/situations as a function of GABRA2 genotype in individuals prior to the initiation of 
alcohol use.  In addition, a longitudinal study assessing GABRA2 genotype in relation to 
measures of anxiety and externalizing behaviors before and after the initiation of alcohol 
use might further elucidate the impact and potential interaction of these GABRA2-
associated phenotypes in relation to alcohol use. 
In contrast to basal anxiety, the current study does not support the idea that CeA 
α2 protein expression is related to alcohol’s anxiolytic capacity.  However, one limitation 
of the current study was that it assessed this capacity with only a single acute exposure.  
Several studies indicate that chronic exposure to alcohol can alter basal GABAergic 
transmission and response to GABAergic drugs in the CeA (Koob, 2004), and it appears 
that these alterations might affect anxiety-like behavior.  Sharko et al. (2013) assessed 
anxiety-like behavior in the EPM using rats with water or low- or high-drinking alcohol 
histories.  High-drinking rats had greater CeA c-Fos expression, and CeA c-Fos 
expression was associated with anxiety-like behavior in alcohol- but not water-drinking 
animals, suggesting alcohol-induced alterations in the relationship between CeA activity 
and anxiety.  Withdrawal from chronic alcohol exposure can also augment CeA 
functioning with respect to anxiety, as infusion of a CRF antagonist in the CeA has been 
shown to be anxiolytic in alcohol-dependent but not non-dependent animals 8 hours post-
exposure (Rassnick et al., 1993).  Lastly, Liu et al. (2011) found a decrease in alcohol 
consumption in rats with virally-mediated CeA Gabra2 knock-down which occurred just 
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3 days after invasive brain surgery, which could be interpreted as a change in the 
negatively-reinforcing capacity of alcohol.  Given that these rats had 21 days of drinking 
history prior to surgery, alcohol-induced changes in CeA functioning could play a role in 
this finding, and it remains to be seen how CeA Gabra2 manipulation would affect 
drinking in alcohol-naïve animals.   
Taken together, the aforementioned studies provide evidence for alcohol history 
as being an important factor in the CeA-alcohol-anxiety relationship and provide 
rationale for future investigations.  Surprisingly, it appears that an assessment of the 
effect of alcohol infusion directly into the CeA on anxiety-like behavior has not been 
conducted.  Performing this assessment in both alcohol-naïve and chronically alcohol-
exposed animals would help to clarify the role of the CeA in alcohol’s anxiolytic capacity 
and address potential augmentation of this role based on prior exposure.  In addition, 
replicating the current study in chronically exposed mice would indicate whether or not 
the relationship between CeA Gabra2 expression and anxiety-like behavior is still 
present after a history of alcohol exposure and whether or not a history of alcohol 
exposure alters the lack of relationship between CeA Gabra2 expression and alcohol’s 
anxiolytic capacity. 
One major limitation of the current study that has yet to be mentioned is that only 
male mice were used, yet gender differences do exist for many of the behaviors 
discussed.  Females have a higher prevalence of anxiety disorders than males even 
though age of onset and duration tend not to differ (McLean, Asnaani, Litz, & Hofmann, 
2011).  In the context of alcohol, females and males with high anxiety sensitivity differ in 
the degree to which the nature of a stressor impacts the acute effects of consumed alcohol 
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(Zack, Poulos, Aramakis, Khamba, & MacLeod, 2007).  With respect to GABRA2, in 
individuals with a risk (of alcohol dependence)-conferring GABRA2 genotype, increased 
levels of positive life events serves as a protective factor for males but not females (Perry 
et al., 2013).  Finally, α2 knock-out and knock-in mice have shown sex-dependent 
differences in alcohol consumption (Blednov et al., 2011; Boehm II et al., 2004).  Given 
these, and other, gender differences, especially regarding anxiety and alcohol use, an 
important future study would be to replicate the current experiment in female mice.   
In summary, CeA α2 protein expression does not appear to be related to alcohol’s 
anxiolytic capacity but does appear to be positively related to basal anxiety.  The CeA 
may be a region where changes in α2 protein expression resulting from GABRA2 
polymorphisms could affect basal anxiety, which in turn could affect alcohol use through 
various routes.  Investigating the role that these subunits play in GABAergic transmission 
within the CeA and its effect on efferent signaling at downstream targets in response to 
anxiogenic or stressful conditions could lead to a better understanding of mechanisms 
underlying the relationship between anxiety and alcohol use. 
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TABLES 
Table 1. Group sizes overall and for specific analyses. 
   All  Exclusions  Used for Analyses 
          GFP Protein Behavior   Brain Behavior Correlations 
Control NI  11  2 0 -  9 - - 
 0  12  6 0 -  6 - - 
 0.75  12  4 0 -  8 - - 
  1.5   12   3 1 -   8 - - 
Virus NI  12  3 1 -  8 - - 
 0  12  2 1 -  9 - - 
 0.75  13  4 1 -  8 - - 
  1.5   12   3 1 -   8 - - 
Total   96  27 5 -  64 - - 
            
   All  Exclusions  Used for Analyses 
          GFP Protein Behavior   Brain Behavior Correlations 
Control NI  11  2 - 0  - 9 - 
 0  12  6 - 0  - 6 - 
 0.75  12  4 - 0  - 8 - 
  1.5   12   3 - 0   - 9 - 
Virus NI  12  3 - 0  - 9 - 
 0  12  2 - 1  - 9 - 
 0.75  13  4 - 0  - 9 - 
  1.5   12   3 - 0   - 9 - 
Total   96  27 - 1  - 68 - 
            
   All  Exclusions  Used for Analyses 
          GFP Protein Behavior   Brain Behavior Correlations 
Control NI  11  - 0 0  - - 11 
 0  12  - 0 0  - - 12 
 0.75  12  - 0 1  - - 11 
  1.5   12   - 2 0   - - 10 
Virus NI  12  - 1 0  - - 11 
 0  12  - 1 1  - - 10 
 0.75  13  - 0 0  - - 13 
  1.5   12   - 1 1   - - 10 
Total   96  - 5 3  - - 88 
            
Note: Mice with multiple exclusions are listed in their leftmost occurring exclusion column. 
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Table 2. Pearson correlations between behavioral measures overall (Top) and between 
normalized (Z-Score) CeA α2 expression and behavioral measures in naïve mice and 
within each ethanol dose (Bottom).  Behavioral measures in parentheses were excluded 
from additional analyses.  ^p < .05, *p < .01, **p < .001 uncorrected for multiple 
comparisons.  Bold values are significant at the more stringent criteria of p < .01. 
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FIGURES 
 
Figure 1.  RNA interference via shRNA.  Illustration taken from (Jolliff, 2007) and 
description synthesized from (Hutvagner & Zamore, 2002; Moore, Guthrie, Huang, & 
Taxman, 2010; S. A. Stewart et al., 2003).  Lentiviral transduction delivers a Gabra2-
targeting genetic sequence which is integrated with a cell’s DNA.  The cell is induced to 
synthesize a double-stranded RNA (dsRNA) comprised of sense and anti-sense sequences 
linked by a short hairpin loop (shRNA), with the anti-sense sequence being 
complementary to endogenous Gabra2 mRNA.  The enzyme Dicer cleaves shRNA into 
small interfering RNA (siRNA) which is incorporated into a protein complex to form an 
RNA-induced silencing complex (RISC).  RISC uses siRNA as a guide to cleave mRNA 
that is complementary to the siRNA, in this case Gabra2.
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Figure 2.  Sandwich ELISA procedure.  Illustration adapted from LifeSpan Biosciences, 
Inc. (lsbio.com).  A) The wells on each ELISA plate come pre-coated with a Gabra2-
specific capture antibody (monoclonal, developed using rats).  B) Samples and standards 
are loaded into wells and incubated, and the excess liquid is removed.  α2 protein should 
remain bound to the capture antibody.  C) A second Gabra2-specific detection antibody 
(polyclonal, developed using rabbits), conjugated with horseradish peroxidase (HRP), is 
added to each well and incubated, and the wells are subsequently washed of unbound 
antibody.  D) HRP substrate solution, containing tetramethylbenzidine, is added to each 
well and incubated, resulting in blue color within each well proportional to α2 protein 
concentration.  A stop solution is then added, ceasing color development.  Finally, the 
optical density of each sample is determined via spectrophotometry at the 450nm 
wavelength using a microplate reader.  
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Figure 3.  EPM behaviors in mice receiving 0, 0.75, 1.0, or 1.5 g/kg ethanol in Aim 1 (n’s 
= 10, 12, 9, 11 (left to right)).  A) All doses of ethanol increased % of entries in open 
arms.  However, there was no significant effect of dose on either (B) time spent in open 
arms or (C) total arm entries.  *p < .05, **p < .01 vs. 0 g/kg.
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Figure 4.  Lentiviral incorporation in the CeA.  A) CeA and surrounding areas under 5x 
magnification in bright field.  C) The same section under 5x magnification with 
fluorescence showing GFP expression in the CeA.  B) A section under 5x magnification 
showing accurate microinjector placement in the CeA; however, this brain showed no 
GFP expression.  D) Mouse brain atlas with the CeA highlighted for reference.
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Figure 5.  CeA α2 protein concentrations.  A) CeA α2 protein concentrations differed 
across ELISA passes (n’s = 3, 8, 8, 12 (left to right)).  B) Normalized (Z-Score) α2 
concentrations were lower for Virus mice than Control mice (n’s = 31, 33 (left to right)).  
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Figure 6.  Arm entries made by naïve mice and mice receiving 0, 0.75, or 1.5 g/kg 
ethanol (n’s = 9, 9, 6, 9, 8, 9, 9, 9 (left to right)).  A) There was no effect of viral 
condition or dose on total arm entries for naïve mice or mice receiving injection.  B) In 
naïve mice or mice receiving injection, there was no effect of viral condition on % of 
entries in open arms.  However, % of entries in open arms was increased for mice 
receiving 0.75 or 1.5 g/kg ethanol.  *p < .05, ***p < .001 vs. 0 g/kg.
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Figure 7.  Total and average time spent in center, closed arms, and open arms by naïve 
mice and mice receiving 0, 0.75, or 1.5 g/kg ethanol (n’s = 9, 9, 6, 9, 8, 9, 9, 9 (left to 
right)).  In naïve mice, there was no effect of viral condition on any time-related measure 
(A-F).  In mice receiving injection, 1.5 g/kg ethanol reduced time spent in center (A) and 
increased time spent in open arms (C).  Also in mice receiving injection, Virus mice 
showed a trend (p = 0.059) towards increased time spent in closed arms (B) and showed 
an increase in average time spent in closed arms (E) compared to Control mice.  There 
was no effect of viral condition or dose on average time spent in center (D) or open arms 
(F).  *p < .05, **p < .01 vs. 0 g/kg, ^p < .05 vs. Control. 
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Figure 8.  Head dips and % protected head dips made by naïve mice and mice receiving 
0, 0.75, or 1.5 g/kg ethanol (n’s = 9, 9, 6, 9, 8, 9, 9, 9 (left to right)).  In naïve mice, there 
was no effect of viral condition on head dips or % protected head dips (A-B).  However, 
in mice receiving injection, 1.5 g/kg ethanol increased head dips (A) and decreased % 
protected head dips (B).  *p < .05, **p < .01 vs. 0 g/kg. 
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Figure 9.  Correlations between α2 protein concentration and behavioral measures in 
naïve mice.  Normalized (Z-Score) α2 protein concentration was positively correlated 
with time spent in closed arms (A) and negatively correlated with both total (B) and 
average (C) time spent in open arms.  Regression lines incorporate both Control and 
Virus data points (n = 11 for each viral condition
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